MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Late-onset THAP-1 with SCA8 expansion mimicking functional movement disorder, case report.

    ZH. Myrzayev, M. Mukhamadiyeva, D. Bagautdinov, CH. Shashkin (Almaty, Kazakhstan)

    Objective: - Background: Functional movement disorders (FMD) are characterized by abnormal movements without an identifiable neurological cause. Diagnosis and management of patients with FMD can…
  • 2026 International Congress

    Detecting Parkinson’s Disease with Postural Sway via Single IMU and Machine Learning

    F. Rashid, R. Fernandez-Rojas, S. Dal, M. Ghahramani (Canberra, Australia)

    Objective: To determine whether simple standing balance tasks, assessed using a single wearable inertial measurement unit (IMU), can effectively differentiate individuals with Parkinson’s disease (PD)…
  • 2026 International Congress

    Biomarker and Clinical Correlates of Restless Legs Syndrome (RLS) in Parkinson’s Disease: A Paradoxical Hyperdopaminergic State

    SM. Fereshtehnejad, J. Valerio, N. Ayas (Vancouver, Canada)

    Objective: To examine the clinical and biomarker correlates of Restless legs syndrome (RLS) in Parkinson’s disease (PD). Background: RLS is more common in PD than…
  • 2026 International Congress

    Exploring Swallowing Dysfunction, Quality of Life, and Caregiver Burden in Multiple System Atrophy

    I. Karagoz, H. Morris, H. Houlden, V. Chelban (London, United Kingdom)

    Objective: To investigate associations between swallowing-related symptoms and disease severity, quality of life, and caregiver burden in patients with MSA in a large UK-based cohort.…
  • 2026 International Congress

    Does PET Imaging Modality Influence Artificial Intelligence Performance in Diagnosing Parkinson’s Disease? Diagnostic Test Accuracy Meta-analysis

    MH. Elkasaby, MSA. Ahmed (Cairo, Egypt)

    Objective: To determine whether AI diagnostic performance for Parkinson’s disease differs across PET imaging platforms Background: PET-based artificial intelligence (AI) has emerged as a promising…
  • 2026 International Congress

    Bridging Genetics and Precision Medicine in Parkinson’s Disease through GP2: Translating Genetic Risk into Trial-Eligible GBA1 and LRRK2 Cohorts

    L. Lange, K. Atterling Brolin, E. Navarro-Jones, M. Tan, S. Meyer, D. Vitale, A. Singleton, C. Blauwendraat, M. Nalls, A. Noyce, H. Morris (Bethesda, USA)

    Objective: To advance precision medicine in Parkinson’s disease (PD) by integrating large-scale clinico-genetic data from diverse populations worldwide and establishing a framework to characterize individuals…
  • 2026 International Congress

    Genetic analysis of Mongolian patients with Parkinson’s Disease

    B. Tserensodnom, KH. Tulgaa (Ulaanbaatar, Mongolia)

    Objective: To investigate the distribution of genetic variants among Mongolian patients with Parkinson’s disease  within the framework of the international GP2 project MONPAR study .…
  • 2026 International Congress

    Aerva Lanata Decoction Alleviates Neuroinflammation And Locomotor Dysfunction In Parkinson Model

    G. Chandran, B. Ramachandra (Mysuru, India)

    Objective: The study focussed on the protective effects of decoction of aerial parts of the Aerva lanata against neuroinflammation, oxidative stress and locomotor deficits against…
  • 2026 International Congress

    Comparison of Non-Motor Outcomes after Subthalamic Nucleus versus Globus Pallidus Internus Deep Brain Stimulation in Parkinson’s disease

    P. Borse, N. Balaini, M. Santhappan Girija, A. Hynse, A. Kishore (Kochi, India)

    Objective: To compare non-motor symptom outcomes after globus pallidus internus (GPi) versus subthalamic nucleus (STN) deep brain stimulation (DBS) in Parkinson’s disease (PD). Background: Non-motor…
  • 2026 International Congress

    Beyond the “best contact”: correlation of ai-guided dbs contact distribution and subthalamic nucleus beta physiology in parkinson’s disease patients

    S. Obika, M. Del Alamo, D. Ortiz-Zacarías, C. Fernandez, F. Alonso-Frech (Madrid, Spain)

    Objective: We hypothesized that optimal stimulation setting may involve a muti-contact configuration rather than a single contact with the largest therapeutic window (TW). We aimed…
  • « Previous Page
  • 1
  • …
  • 70
  • 71
  • 72
  • 73
  • 74
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley